19 February 2019 - Insulin prices are killing people. 

A single vial, which lasts some users between one and two weeks, is priced over $300 — roughly triple what it cost in 2002. One in 4 diabetes patients have admitted to rationing the drug because of costs, and several have died after doing so.

Much to the relief of insulin affordability advocates, who have been raising awareness about costs and pushing for policy changes, the public is increasingly aware of this crisis. But instead of working with advocates to rectify the situation, too many people are simply promoting older, cheaper insulin. This was evident in early February when a Facebook post touting “Walmart insulin” went viral. Such gestures come from a good place, but they put insulin-dependent people at greater risk and threaten to exacerbate the larger problem.

Read Washington Post article